Zydus completes Phase II(a) clinical study of NLRP3 inhibitor ‘Usnoflast’ in ALS patients, ET HealthWorld Ahmedabad: …
Latest in Health
-
Health
UnitedHealth to remove AbbVie’s Humira from some US drug reimbursement lists next year, ET HealthWorld
UnitedHealth to remove AbbVie’s Humira from some US drug reimbursement lists next year, ET HealthWorld By …
-
Viridian’s drug cuts thyroid eye disease symptoms in late-stage study, ET HealthWorld By Mariam Sunny London: …
-
Health
EU set to fine Teva for disparaging rival multiple sclerosis medicine, sources say, ET HealthWorld
EU set to fine Teva for disparaging rival multiple sclerosis medicine, sources say, ET HealthWorld London: …
-
China’s drug regulator clears mpox vaccine; to undergo clinical trial, ET HealthWorld Beijing: China’s top drug …
-
‘Female rage’: Edmonton woman sparks airplane ‘manspreading’ debate There’s no doubt that flying has become worse …
-
German chemicals sector recovery loses momentum in Q2, says industry group, ET HealthWorld London: A slight …
Weight-loss market to see 16 new drugs by 2029, report estimates, ET HealthWorld London: The market …
Back-to-school lunches: Dietitian tips for avoiding ultra-processed foods – National With the start of a new …
European shares hold ground as AstraZeneca drags, tech shares rise, ET HealthWorld London: European shares were …
Health news offers insights into the latest discoveries, breakthroughs, and debates in healthcare. It delivers updates through articles, podcasts, and videos, showcasing progress across medical disciplines.
Coverage spans medicine, nutrition, mental health, and fitness, providing insights into healthy living and preventing illnesses. Additionally, health news explores the implications of research on well-being and public health policies, fostering informed discussions.
In our ever-evolving world, it serves as a vital resource for staying informed and promoting personal health awareness.